期刊文献+

姜黄素联合顺铂对非小细胞肺癌细胞A549放疗增敏作用的初步研究 被引量:11

A preliminary study on radiosensitization effect of curcumin plus cisplatin on non-small cell lung cancer A549 cells
下载PDF
导出
摘要 目的探讨姜黄素联合顺铂对非小细胞肺癌细胞A549放射增敏的影响。方法采用MTT法观察不同浓度姜黄素(10、20、50、100、200μmol/L)和顺铂(1、2、5、10、20 mg/L)作用24、48及72 h后的细胞存活率,根据实验设计分为单纯照射(R)组、姜黄素+照射(C+R)组、顺铂+照射(P+R)组及姜黄素+顺铂+照射(C+P+R)组,采用克隆形成实验检测4组经不同剂量X线(0、2、4、6、8、10 Gy)照射后的存活分数(SF)并通过单击多靶模型拟合细胞存活曲线计算增敏比(SER),分别采用人工划痕、Transwell试验及Western blotting检测以上4组处理24 h后的细胞迁移、侵袭及表皮生长因子受体(EGFR)的蛋白水平。结果随姜黄素(10-200μmol/L范围内)和顺铂(1-20 mg/L范围内)浓度增加,A549细胞的细胞存活率降低,抑制效应呈浓度和时间依赖方式,差异有统计学意义(P〈0.05);C+P+R组在照射剂量为2-10 Gy时的细胞SF均低于其余3组,而C+R组在4-10 Gy,P+R组在2-10 Gy时的细胞SF均低于R组,差异有统计学意义(P〈0.05),C+R组、P+R组及C+P+R组相对于R组的SER依次为1.24、1.31和1.96;C+P+R组的迁移距离、穿膜细胞数量及EGFR蛋白水平均低于其余3组,而C+R组和P+R组的以上指标亦低于R组,以上差异均有统计学意义(P〈0.05)。结论姜黄素联合顺铂可抑制A549细胞增殖并具有放射增敏作用,同时抑制其迁移和侵袭,可能与EGFR相关信号通路受抑制有关。 Objective To explore the radiosensitization effect of curcumin plus cisplatin on non-small cell lung cancer A549 cells. Methods Cell viability at 24,48 and 72 h after treatment with different concentrations( 10,20,50,100,200 μmol / L) of curcumin or( 1,2,5,10,20 mg / L) of cisplatin were determined by MTT. According to the experimental protocol,the below experiments were carried out in irradiation( R) group,curcumin + irradiation( C + R) group,cisplatin + irradiation( P + R) group and curcumin + cisplatin + irradiation( C + P + R) group. The colony formation assay was employed to observe the surviving fraction( SF) of above four groups after X-ray irradiation of 0,2,4,6,8,10 Gy. The artificial scratch,Transwell test and Western blotting were employed to detect the cell migration,invasion and protein level of epidermal growth factor receptor( EGFR) at 24 h after treatment in four groups. Results The cell viability of A549 cells gradually decreased with the increasing concentration of curcumin ranging from 10 to200 μmol / L and cisplatin ranging from 1 to 20 mg / L in a dose- and time-dependent manner( P〈0. 05). The SF of C + P + R group were lower than the remaining 3 groups under the dose of 2-10 Gy( P〈0. 05). Compared with the R irradiation group,there was lower SF in C + R group under the dose of 4-10 Gy and P + R group under the dose of 2-10 Gy with significant difference( P〈0. 05). Compared with R group,the sensitizing enhancement ratio were 1. 24,1. 31 and 1. 96 in C + R group,P + R group and C + P + R group,respectively.There were lower migration distance,transmembrane cell number and EGFR protein level in C + P + R group versus the remaining 3groups( P〈0. 05). Compared with the R group,the above indicators were also lower in C + R group and P + R group under the dose of2-10 Gy with significant difference( P〈0. 05). Conclusion Curcumin plus cisplatin can inhibit the proliferation of A549 cells with radios
作者 蔡勇 王季颖
出处 《临床肿瘤学杂志》 CAS 2015年第1期13-17,共5页 Chinese Clinical Oncology
关键词 姜黄素 顺铂 放疗增敏 表皮生长因子受体 Curcumin Cisplatin Radiosensitization effect Epidermal growth factor receptor
  • 相关文献

参考文献15

二级参考文献94

  • 1Kawiya Sintara,Duangporn Thong-Ngam,Suthiluk Patumraj,Naruemon Klaikeaw,Tanittha Chatsuwan.Curcumin suppresses gastric NF-κB activation and macromolecular leakage in Helicobacter pylori-infected rats[J].World Journal of Gastroenterology,2010,16(32):4039-4046. 被引量:28
  • 2田德增,朱辉,梁永杰.姜黄素对肺腺癌A549细胞凋亡的影响及其机制[J].中国临床药学杂志,2006,15(1):8-10. 被引量:6
  • 3匡双玉,庹勤慧,朱炳阳,梁磊,李熠,罗迪贤,许灿新,廖端芳.姜黄素对血管平滑肌细胞源性荷脂细胞胆固醇代谢及SREBP-1表达的影响[J].南华大学学报(医学版),2006,34(3):317-319. 被引量:6
  • 4Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med, 1992, 327(23): 1618-1624. 被引量:1
  • 5Kumar E The role of thoracic radiotherapy in the management of limitedstage small cell lung cancer: past, present, and future. Chest, 1997, 112(4 Suppl): 259S-265S. 被引量:1
  • 6De Ruysscher D, Vansteenkiste J. Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects. Radiother Oncol, 2000, 55(1): 1-9. 被引量:1
  • 7Work E, Nielsen OS, Bentzen SM, et al. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small- cell lung cancer. Aarhus Lung Cancer Group. J Clin Oncol, 1997, 15(9): 3030-3037. 被引量:1
  • 8Perry MC, Hemdon JE 3rd, Eaton WL, et al. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083.J Clin Oncol, 1998, 16(7): 2466-2467. 被引量:1
  • 9Jeremic B, Shibamoto Y, Acimovic L, et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited sman-ceU lung cancer: a randomized study. J Clin Oncol, 1997, 15(3): 893-900. 被引量:1
  • 10Skarlos DV, Samantas E, Briassoulis E, et al. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase Ⅱ study of the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol, 2001, 12(9): 1231-1238. 被引量:1

共引文献52

同被引文献124

引证文献11

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部